Publications by authors named "Vignesh Packiam"

Claim this Profile
T
The Future of Bladder Preservation for Muscle-invasive Bladder Cancer.
Melinda Z Fu, Saum Ghodoussipour, Vignesh T Packiam

Eur Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Comment.
Melinda Z Fu, Saum Ghodoussipour, Vignesh T Packiam

J Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of an Artificial Intelligence-powered Predictive Biomarker Is Associated with a Poor Response to Intravesical Bacillus Calmette-Guerin but Not to Intravesical Sequential Gemcitabine/Docetaxel in Patients with High-grade Non-muscle-invasive Bladder Cancer.
Vignesh T Packiam, Ian M McElree, Saum Ghodoussipour, Vivek Nimgaonkar, Viswesh Krishna

Eur Urol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Bladder-preserving Trimodality Treatment for High-grade T1 Bladder Cancer: Results from Phase II Protocol NRG Oncology/RTOG 0926.
Melinda Z Fu, Saum Ghodoussipour, Vignesh T Packiam

Eur Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended Outcomes of Intravesical Valrubicin and Docetaxel as a Secondary Salvage Treatment for Recalcitrant High-risk Non-muscle-invasive Bladder Cancer.
Ian M McElree, Ryan L Steinberg, Helen Y Hougen, Sarah L Mott, Vignesh T Packiam

Eur Urol Focus· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative outcomes of radical nephroureterectomy and kidney-sparing surgery in the treatment of high-grade upper tract urothelial carcinoma.
Kyle Moore, Helen Gao, Benjamin Lichtbroun, Jennifer Delgado, Anirudh Kulkarni, Vignesh T Packiam

Urol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-releasing intravesical floating technology for sequential gemcitabine and docetaxel in non-muscle-invasive bladder cancer.
Ashley C Rhodes, Kaitlyn A McClintic, Emily Witt, Ikenna Nwosu, Kyle R Balk, Vignesh T Packiam

BJU Int· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational Histology Artificial Intelligence (CHAI) Enhances Risk Stratification of High-grade Ta Non-muscle-invasive Bladder Cancer in a Multicenter Cohort: Comparison to Current European Association of Urology and American Urological Association Stratification Schemes.
Sam S Chang, Bryn Launer, Vikram Narayan, Dattatraya Patil, Michael A O'Donnell, Vignesh T Packiam

Eur Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin-unresponsive Carcinoma in Situ of the Bladder.
Amanda A Myers, Ruchika Talwar, Zhigang Duan, Patrick Hensley, Yair Lotan, Vignesh T Packiam

Eur Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of a cascading salvage strategy for high-risk non-muscle-invasive bladder cancer.
Ian M McElree, Ryan L Steinberg, Helen Y Hougen, Sarah L Mott, Vignesh T Packiam

BJU Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bladder-sparing management for high grade noninvasive urothelial carcinoma of the prostate.
Alexander C Martin, Ian M McElree, Sarah L Mott, Helen Y Hougen, Ryan L Steinberg, Vignesh T Packiam

Urol Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avelumab and taxol chemotherapy in platinum-refractory or ineligible metastatic urothelial carcinoma (AVETAX trial).
Rohan Garje, Aditya Ravindra, Bilal Rahim, Mathew Kroll, Jeffrey S Johnson, Vignesh T Packiam

Urol Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the efficacy and safety of sequential intravesical gemcitabine and docetaxel - does time from transurethral resection of bladder tumour to induction matter?
Ian M McElree, Grant M Henning, Ryan L Steinberg, Helen Y Hougen, Sarah L Mott, Vignesh T Packiam

BJU Int· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of sequential intravesical gemcitabine and docetaxel versus BCG for the treatment of European association of urology very-high risk non-muscle invasive bladder cancer.
Mohamad Abou Chakra, Vignesh T Packiam, Ian M McElree, Sarah L Mott, Michael A O'Donnell

Urol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Comment.
Melinda Z Fu, Vignesh T Packiam

J Urol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non-muscle-invasive Bladder Cancer Undergoing Bladder-sparing Therapies.
Drupad Annapureddy, Jacob I Taylor, Ashish M Kamat, Michael A O'Donnell, Jeffrey Howard, Vignesh T Packiam

Eur Urol Focus· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of blue light cystoscopy and additional operative evaluations during first surveillance after induction therapy for high-risk NMIBC.
Ian M McElree, Ryan L Steinberg, Sarah L Mott, Helen Y Hougen, Michael A O'Donnell, Vignesh T Packiam

Bladder Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin-Unresponsive Non-Muscle Invasive Bladder Cancer.
Jacob Taylor, Ashish M Kamat, Drupad Annapureddy, Zine-Eddine Khene, Jeffrey Howard, Vignesh T Packiam

Eur Urol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rethinking the definition of stage III disease in adrenocortical carcinoma: Assessing the impact of clinical lymph node positive disease.
Benjamin J Lichtbroun, Helen Gao, Kevin Chua, John Pfail, Rachel Passarelli, Vignesh T Packiam

Urol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability and efficacy of induction Bacillus Calmette-Guérin for non-muscle invasive bladder cancer.
Mann Patel, Aravind Rajagopalan, Ellen M Cahill, Kevin J Chua, Rachel Passarelli, Vignesh T Packiam

Bladder (San Franc)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transperineal prostate biopsy without routine antibiotics demonstrates decreased infection risk.
Benjamin J Lichtbroun, Mann Patel, Alexis Consalvo, Labeeqa Khizir, Munisa Said, Vignesh T Packiam

Can J Urol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Comment.
Rachel Passarelli, Benjamin Lichtbroun, Saum Ghodoussipour, Vignesh T Packiam

J Urol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential Endoluminal Doxorubicin and Gemcitabine Alternating Weekly with Sequential Mitomycin and Docetaxel for Recurrent Non-Muscle Invasive Urothelial Carcinoma.
Ian M McElree, Vignesh T Packiam, Ryan L Steinberg, Helen Y Hougen, Mohamad Abou Chakra

Cancers (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bladder sparing management for muscle-invasive bladder cancer after a complete clinical response: ready for prime time?-a narrative review.
Mann Patel, Kyle Moore, Benjamin L Lichtbroun, Ryan D Stephenson, Tina Mayer, Vignesh T Packiam

Transl Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Landscape and prognostic significance of oncogene drivers in metastatic castration sensitive prostate cancer.
Theodore Wang, Jongmyung Kim, Ritesh Kumar, Rebecca A Deek, Ryan Stephenson, Vignesh Packiam

Transl Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis